Sponsor

Hangzhou Hospital of Traditional Chinese Medicine

Clinical research sponsor

Published trials4
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

4 shown
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label TrialNCT06863532 · collaborator · 2025-03-30
RECRUITING
Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western MedicineNCT05459805 · collaborator · 2022-03-01
UNKNOWN
Observational Study of ASCVD Risks of Type 2 Diabetes in East ChinaNCT04866667 · collaborator · 2021-05-01
COMPLETED
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer PatientsNCT03123770 · collaborator · 2016-12-01
UNKNOWN

Sponsor roles

collaborator4

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.